The sampling of interstitial fluid for real-time assay requires techniques that are sensitive, rapid, painless, minimally invasive and easy to use by patients. Microneedles can be incorporated into biosensors with subsequent use of these platforms for continuous monitoring or bio-chemical detection of analytes in the dermal interstitial fluid. Supports the goal of SDG 3.8 to achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.
Elsevier,
Diabetes Without Needles, Non-invasive Diagnostics and Health Management, 2022, Pages 27-92
Introduces diabetes including past, present, and future achievements in this field. The goal of SDG target 3.4.1 is to reduce the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
Elsevier,
The COVID-19 Response: The Vital Role of the Public Health Professional, 2023, Pages 143-154
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining the role of social determinants and racism in COVID's inequitable impacts, the burnout of the workforce, and the politicization of the response as major factors that will influence the future of the public health system.
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial pharmaceutical applications of marine-derived compounds.
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial nutritional applications of marine-derived lipids.
This chapter advances SDGs 3, 4, and 10 by exploring topics with emphasis on the benefits and challenges of talking with youth about race and identity, strategies for coping, and ways that we can help promote racial healing in ourselves and our communities.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing coverage of the clinical syndrome of a primary progressive aphasia (PPA), the demographics of this rare neurodegenerative disease, defining clinical and neuroanatomic characteristics of each PPA variant, disease progression, and behavioral features.
This chapter advances the UN SDG goals 3 and 17 by brings together medical and computational domains to discuss the use of deep learning (DL) and machine learning (ML) in the early detection of AD.
Elsevier,
Autophagy Dysfunction in Alzheimer's Disease and Dementia, First Edition, 2022, pp 263-290
This chapter advances the UN SDG goals 3 and 17 by reviewing recent drug discoveries and autophagy regulation which is essential for the treatment of AD.
Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
